[1] LAZAR S, MICHELLE KAHLENBERG J. Systemic lupus erythematosus: new diagnostic and therapeutic approaches[J]. Annu Rev Med, 2023, 74: 339-352.
[2] KIRIAKIDOU M, CHINGC L. Systemic lupus erythematosus[J]. Ann Intern Med, 2020, 172(11): ITC81-ITC96.
[3] MIRABELLI G, CANNARILE F, BRUNI C, et al. One year in review 2015:systemic lupus erythematosus[J]. Clin Exp Rheumatol, 2015, 33(3): 414-425.
[4] SARWAR S, MOHAMEDA S, ROGERS S, et al. Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges[J]. Cureus, 2021, 13(9): e17969.
[5] KIVITY S, AGMON-LEVIN N, ZANDMAN-GODDARD G, et al. Neuropsychiatric lupus: a mosaic of clinical presentations[J]. BMC Med, 2015, 13: 43.
[6] LUYENDIJK J, STEENSS A, OUWENDIJK W N, et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging[J]. Arthritis Rheum, 2011, 63(3): 722-732.
[7] FLORICA B, AGHDASSI E, SU J, et al. Peripheral neuropathy in patients with systemic lupus erythematosus[J]. Semin Arthritis Rheum, 2011, 41(2): 203-211.
[8] BERTSIASG K, IOANNIDIS J A, ARINGER M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs[J]. Ann Rheum Dis, 2010, 69(12): 2074-2082.
[9] TOKUNAGA M, SAITO K, KAWABATA D, et al. Efficacy of rituximab(anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system[J]. Ann Rheum Dis, 2007, 66(4): 470-475. |
